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Abstract
Background: Mathematical modeling in epidemiology (MME) is being used increasingly. However, there are many
uncertainties in terms of definitions, uses and quality features of MME.
Methodology/Principal Findings: To delineate the current status of these models, a 10-item questionnaire on MME was
devised. Proposed via an anonymous internet-based survey, the questionnaire was completed by 189 scientists who had
published in the domain of MME. A small minority (18%) of respondents claimed to have in mind a concise definition of
MME. Some techniques were identified by the researchers as characterizing MME (e.g. Markov models), while others–at the
same level of sophistication in terms of mathematics–were not (e.g. Cox regression). The researchers’ opinions were also
contrasted about the potential applications of MME, perceived as higly relevant for providing insight into complex
mechanisms and less relevant for identifying causal factors. The quality criteria were those of good science and were not
related to the size and the nature of the public health problems addressed.
Conclusions/Significance: This study shows that perceptions on the nature, uses and quality criteria of MME are contrasted,
even among the very community of published authors in this domain. Nevertheless, MME is an emerging discipline in
epidemiology and this study underlines that it is associated with specific areas of application and methods. The
development of this discipline is likely to deserve a framework providing recommendations and guidance at various steps of
the studies, from design to report.
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Introduction
The increased use of mathematical modeling in epidemiology
(MME) is widely acknowledged [1]. When data are not there, or not
yet there, MME provides rationales in Public Health problems to
support decisions in Public Health, and this constitutes one of the
reasons for the increased use of MME, For example, some models
have been proposed for estimating non observable putative risks of
importance in terms of public health, such as the risk of cancer after
exposure to diagnostic radiations [2], the residual infectious risks in
blood transfusion [3], or the future size of a the epidemic of an
emergent disease [4]. MME is also unavoidable in economic studies
[5,6] and has been used for studying the dynamics and control of
epidemics of infectious diseases [7]. For example MME has been
widely applied to influenza pandemics (see among many references,
refs [8,9,10,11]). In addition, MME provides insights on the role of
possible determinants of diseases that were overlooked in the
traditional epidemiological approaches: for example Christakis et al
reanalyzed the iconic Framingham studies and showed that some
network sociological properties could explain observed trends in the
incidence of several chronic diseases [12,13].
The above list of key public health domains attests for the
diversity and interest of problems for which MME might be
involved in supporting public decision. Such an involvement both
reassures and worries the decision makers and the public at large
who eventually have concerns on the nature of the science of
MME. Indeed, the heterogeneity of the methods used in MME, as
well as the diversity of the problems addressed raises several
questions: is there a simple shared definition for this emerging
scientific discipline? Is MME only mainly aimed to answer
questions of decision makers, or is it a scientific discipline of its
own? What are the criteria of good science in MME? To answer
these questions, we chose to collect the opinions of the scientists
who actually do MME. We present here the results that were
observed on a panel of scientists who participated in a web-based
survey investigating the above issues.
Materials and Methods
Survey participants
We constituted a panel of researchers who had published
academic papers in the field of MME through a search in the
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Figure 1. The questionnaire of the survey.
doi:10.1371/journal.pone.0016531.g001
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Science Citation Index database via the Web of Sciences
(Thomson Reuters, NY). In a query made on February 2, 2007,
we identified all papers published since 2002 containing the terms
‘‘mathematical model*’’ (* is a wildcard end of the term) in the
title, the abstract, or among the keywords and published in a
journal belonging to at least one of the six following categories of
the Journal of Citation Reports (Thomson Reuters, NY): public,
environmental & occupational health; infectious diseases; oncol-
ogy; medicine, research & experimental; social sciences, mathe-
matical methods; medicine, general & internal. This search
retrieved 920 articles. The email address of the corresponding
author was documented in the Web of Science records for 529 of
the 920 papers, yielding one email address for 482 different
authors. We manually searched for the email addresses of the
corresponding authors of the 391 remaining articles, which in turn
provided a second series of 301 additional email addresses. In the
end, 126 of the total 783 addresses returned an error message,
being wrong or more likely obsolete. Finally, we obtained a list of
657 authors with a valid email.
We emailed these 657 authors to invite them to participate
anonymously in our survey, as we provided each author with an
anonymous and personal login. The survey was developed through
the Internet using phpESP freeware [14]. Our website hosted the
survey and was open during two periods: from October 11 to
October 27, and from November 11 to December 8, 2007. During
these periods, reminders were sent to all the potential participants.
Each participant was asked to provide his age, background,
present academic position and country of work. The survey was
completed by 189 participants (29% response rate) who constitut-
ed the panel herein analyzed. 49% of the respondents were under
45 years old. Most (75%) participants answered that they had a
background in mathematics or physics; 40% were university
teachers or researchers, 36% were researchers with institution
responsibilities (faculty head, institute head, department head, lab
head, research director, or senior researcher), 9% were postdoc-
toral researchers, and 6% were senior medical doctors. The
percentages of participants working in America, Europe, Asia,
Africa and Australia, were respectively 46% (including 36% from
the USA and 5% from Canada), 38% (including 12% from U.K.),
8%, 2% and 6%.
Questionnaire
The questionnaire was composed of ten one-minute questions
(Figure 1). The answer required for questions Q3 to Q8 was
obtained by clicking on a 9-point scale, with 1 corresponding to
‘‘not relevant at all’’, and 9 to ‘‘very relevant’’. Questions Q1 and
Q2 concerned the author’s definitions of a MME. Questions Q3 to
Q5 investigated the conceptual objectives of MME (Q3 and Q5)
and public health domains of applications (Q4). The five
remaining questions (Q6–Q10) explored quality and success
features associated with the use of these models: three questions
examined criteria for quality (Q6 and Q7) and success (Q8); Q9
evaluated whether the panelists perceived a difference between the
strengths of conviction of the results derived from statistical
Figure 2. Perceived relevances of nine techniques for qualify-
ing a study in the field of mathematical modeling in
epidemiology (MME).
doi:10.1371/journal.pone.0016531.g002
Figure 3. Perceived role of mathematical modeling in epidemiology (MME). Means and standard error (SE) of the responses obtained for
each item are shown. Respondents scored each item on a 1–9 scale (1 = not relevant at all, 9 = very relevant). Top panel: items from questions Q3
and Q5; bottom panel: items from question Q4. The exact formulations of questions Q3 to Q5 are in Figure 1.
doi:10.1371/journal.pone.0016531.g003
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epidemiology and those from MME. Finally, we asked the
participants their opinions on the statement ‘‘All models are
wrong, some may be useful’’ (Q10), made by the statistician
George Box who co-authored the Box and Jenkins method [15].
Statistical analysis
Answers to Q1 were recoded on an ordinal 3-point scale (‘‘no’’,
‘‘can’t say’’ and ‘‘yes’’ were respectively recoded as 1, 2 and 3), as
were responses to Q9 (‘‘never’’, ‘‘sometimes’’ and ‘‘often’’ were
respectively recoded as 1, 2 and 3). Considering all the items
investigated in Q1 and in Q3–Q9, the respondents’ answers to the
items of a question (or a group of questions) were handled as
measures issued from a complete block design, the first (fixed)
factor being the explored item, the second (block, random) factor
being the respondent. Therefore, when analyzing the potential
differences in the responses to several items, we performed
multiple comparisons between all considered items using the
Wilcoxon–Nemenyi–McDonald–Thompson procedure recom-
mended by Hollander and Wolfe [16]. This procedure identifies
potential clusters of items, with a non-significant (P.0.05)
difference between any two items belonging to a given cluster
and, conversely, a significant (P#0.05) difference between any two
items belonging to two distinct clusters. R statistical software [17],
version 2.9.0, was used for all analyses.
Results
Considering the definition of MME addressed in question Q2,
22% of the respondents answered that no such definition exists,
and 60% indicated that they would need (more) time to state it.
Question Q1 investigated whether the uses of 9 mathematical or
statistical methods frequently used in epidemiology were judged by
the panel as characterizing the field of MME. The multiple
comparison analysis identified three clusters of items (Figure 2).
The first cluster groups items (Monte-Carlo simulation, differential
equations, Markov model, basic reproduction number R0) for
which most respondents considered that the use of the technique
in the analysis qualifies the study as belonging to the MME field.
In contrast, standard statistical epidemiological techniques (logistic
regression, Cox regression and computation of odds ratio)
constituted a second cluster of items for which only a small
minority of respondents considered their use is sufficient to qualify
the study as belonging to the MME domain. The intermediate
cluster was comprised of multilevel models and back-calculation.
Multilevel models, which are plain statistical techniques, were
placed in this intermediate group, not in the statistical tools’
category, and back-calculation was considered by only a minority
of the respondents as qualifying a study as belonging to MME.
The eight different possible roles and five domains of application
of MME suggested were ranked by the participants (Figure 3). The
most prominent MME roles identified by the respondents were the
capacity to provide insight into a complex mechanism and, in terms
of health policy, to explore intervention scenarios and to support
decision-making. At the opposite end, the least recognized MME
role was the identification of causal factors. The possible use of
MME to investigate putative presently undemonstrated risks
received a very low rating. Finally, the respondents clearly ranked
the different domains of application, putting infectious diseases at
the top and chronic diseases at the bottom.
The last dimension explored in the survey addressed the
perceived determinants of a ‘‘good MME’’, in terms of quality and
success (Figure 4). The criteria of the panel are (not surprisingly)
academic, as evidenced by the ranking of the quality features. The
fact that the MME has originated from an official request got the
lowest ranking, and even the fact of being used in practice by
decision-makers was rated low. Academic values, again, were
considered as the main criteria of success of MME (Figure 4).
Indeed, the major perceived success of a model is to be published
in good scientific journals, not in the lay press. No significant
difference was found between public health domains in terms of
the perceived strength of conviction provided by statistical or
mathematical epidemiology (Table 1). Box’s provocative remark
was endorsed by 65% of the respondents, 20% disagreed, and
15% labeled it as ‘‘reflecting a deep ignorance of MME’’.
Figure 4. Perceived quality and success features of mathematical modeling in epidemiology. Means and standard error (SE) of the
responses obtained for each item are shown. Respondents scored each item on a 1–9 scale (1 = not relevant at all, 9 = very relevant). Top panel:
items from questions Q6 and Q7; bottom panel: items from question Q8. The exact formulation of questions Q6 to Q8 are in Figure 1.
doi:10.1371/journal.pone.0016531.g004
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Discussion
The response rate to the present survey was 29%, within the
range of the rate reported for Web-based surveys (median at 27%)
[18]. This rate does not impact our results. The purpose of our
work was not to provide figures on the perception of MME in
researchers or epidemiologists at large, but to rank these
perceptions. For example, the panel researchers’ much higher
ranking of MME relevance in infectious disease than in chronic
diseases can certainly be safely extrapolated. This is the usual
situation in epidemiology: absolute values observed on a particular
study are difficult to extrapolate, but differences and correlations
within the group can be safely extrapolated.
The first question we posed was about the identity ofMME, given
the large diversity of methods and uses, as underlined by Weinstein
et al [19]. The results show that the use of statistical ‘‘models’’, such
as the Cox Model, is not considered by the researchers as qualifying
a work as in the field of MME, while conversely, Monte Carlo
simulations, Markov models and differential equations are. The use
of the basic reproductive number in a paper was also considered as a
good indicator of MME, with a more modest score achieved (51%)
that might be due to the fact that R0 is increasingly viewed as a
general epidemiological concept. Conversely, even if back-calcula-
tion can be considered as a historical success story of mathematical
epidemiology [20], it is however viewed more as a statistical
technique, computationally demanding. All in all, mathematical
modelers appear to characterize models more by the abstraction of
the representation of the epidemiological mechanisms studied (e.g.
transmission, immunity) than by the sophistication of the underlying
mathematical tools.
The second question aimed at delineating the limits of what
models can and cannot do from the point of view of those who
produce them. The answers are that MME is more suited for
clarifying the laws underlying complex mechanisms, for support-
ing decision-making, and for exploring intervention scenarios.
MME is not perceived as competing with standard epidemiology
for the discovery of the causes of the diseases and/or risk factors.
Infectious diseases, emerging risks and diseases, and environmental
risks, were scored as domains for which MME is highly applicable.
The third question aimed at identifying the determinants of a
‘‘good’’ model. Keeling and Rohani stated that what constitutes a
good model depends on the context [21]. Notably, modelers think
that decision-making is an important goal of MME but do not
consider practical use of their models by health authorities for
decision-making as an adequate criterion of MME quality.
Modelers acknowledge the gap between their scientific output
and public uses of it to which they are not automatically
associated. The quality features perceived by the respondents all
relate to scientific excellence. The finding that the values of the
mathematical modelers in epidemiology are clearly academic has
two practical consequences. First, scientific policy makers and
proposal evaluators in the field of MME should be aware that
these researchers expect that an assessment of their projects, works
and even careers be primarily based on their intrinsic scientific
quality, not their public health ‘‘usefulness’’. Second, public health
decision-makers should keep that finding in mind, when modelers
do not provide quick and simple answers to the problems they
pose; above all, modelers are driven in their agendas by the quality
and originality of the methods they develop, even when the
general direction of their work is oriented by important public
health issues.
In conclusion, this study shows that perceptions on the nature,
uses and quality criteria of MME are contrasted, even among the
very community of published authors in this domain. Nevertheless,
MME is an emerging discipline in epidemiology and this study
underlines that it is associated with specific areas of application
and methods. The development of this discipline is likely to
deserve a framework providing recommendations and guidance at
various steps of the studies, from design to report. Previous similar
proposals in other domains of epidemiology have been successful.
For example, CONSORT guidelines in the domain of clinical
randomized trials [22,23], represent a prototype of what could be
done in the domain of MME.
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